In a study that examined galectin-3 (Gal-3) expression by tissue microarray constructed from 83 patients who underwent prostatectomy (83 tumor, 78 adjacent benign, and 75 benign tissues), it was shown that Gal-3 expression was significantly decreased in tumor tissue compared to benign (84). This evidence concerns the gene LGALS3 and neoplasm.